Bausch + Lomb acquires Blink eye drop products from Johnson & Johnson Vision
Click Here to Manage Email Alerts
Key takeaways:
- A Bausch + Lomb affiliate purchased the Blink product line from Johnson & Johnson Vision.
- The acquisition includes eye and contact lens drops.
An affiliate of Bausch + Lomb acquired the over-the-counter Blink product line of eye and contact lens drops from Johnson & Johnson Vision, according to a press release.
“Eye dryness can often be addressed first at home with over-the-counter (OTC) eye care products. For many eye care professionals, and the patients they serve, it’s about finding the right solution for their needs,” John Ferris, executive vice president, consumer, Bausch + Lomb, told Healio. “Eye care professionals can recommend the Blink line of eye drops as a potential OTC option for their patients who are seeking immediate and long-lasting symptom relief.”
Bausch + Lomb will pay $106.5 million with cash on hand for the product line.
The acquisition includes Blink Tears lubricating eye drops, Blink Tears preservative-free lubricating eye drops, Blink GelTears lubricating eye drops, Blink Triple Care lubricating eye drops, Blink Contacts lubricating eye drops and Blink-N-Clean lens drops.
“The acquisition of the Blink OTC product line provides scale to our broad OTC portfolio, which includes eye and contact lens drops from the company’s Biotrue, Soothe and Artelac consumer brand franchises,” Ferris said. “Dry eyes are on the rise, especially due to time spent on digital devices. With the addition of Blink, we have an exciting opportunity to increase OTC consumer convenience in eye care by providing more options to help relieve the symptoms of dry eyes and dry contact lenses.”
Editor's note: This article was updated on July 10, 2023, to add comments from John Ferris.
Read more about
Click Here to Manage Email Alerts